(Q39247909)
Statements
Phosphoinositide 3-kinase (PI3K) pathway alterations are associated with histologic subtypes and are predictive of sensitivity to PI3K inhibitors in lung cancer preclinical models (English)
Jill M Spoerke
Carol O'Brien
Ling Huw
Hartmut Koeppen
Jane Fridlyand
Rainer K Brachmann
Peter M Haverty
Ajay Pandita
Sankar Mohan
Deepak Sampath
Lori S Friedman
Leanne Ross
Garret M Hampton
Lukas C Amler
David S Shames
7 November 2012